|
HY-122639-10mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-100mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-25mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-5mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-50mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-12501-10mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-5mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-50mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-10mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-5mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-50mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-125331-10mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-100mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-25mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-5mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-50mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-144898-10mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
|
HY-144898-100mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
|
HY-144898-25mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
|
HY-144898-5mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
|
HY-144898-50mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
|
HY-14808-10mg
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14808-5mg
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14808-50mg
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14899-10mg
|
MedChemexpress LLC
|
Taprenepag [CAS 752187-80-7]
|
|
|
|
